Clinical Exome Sequencing (CES) in India: Comprehensive Genetic Testing for Rare Diseases
At a Glance
- Sample Required: Blood or Saliva
- Fasting Rules: No fasting required
- Turnaround Time (TAT): 4–5 weeks
- Base Cost: ₹20,000
Clinical Exome Sequencing: Definition and Scope
Clinical Exome Sequencing (CES) is an advanced DNA test that analyzes all clinically relevant coding regions of the genome to identify genetic variations linked to health conditions. Using Next-Generation Sequencing (NGS) technology, CES provides accurate, comprehensive, and cost-effective insights into rare genetic disorders, complex diseases, and pharmacogenomic responses.
The Clinical Exome Sequencing test targets the exome, the protein-coding portion of the genome, which makes up about 1% of our DNA but contains up to 85% of disease-causing variants. CES screens all clinically validated genes to detect mutations or variants responsible for genetic conditions, such as:
- Mendelian disorders like Huntington’s disease
- Somatic variants linked to cancers
- Complex conditions like autism and Alzheimer’s disease
- Genetic factors influencing drug response
CES is particularly useful when other genetic tests fail to identify the cause of health or developmental issues.
The Role of Next-Generation Sequencing (NGS) in CES
NGS is a high-throughput sequencing technology that allows multiple genes to be sequenced simultaneously, providing faster and more accurate results compared to traditional Sanger sequencing. Advantages of NGS include:
- Comprehensive gene analysis in a single test
- Rapid turnaround time
- Higher accuracy for detecting pathogenic, benign, or variants of unknown significance (VUS)
- Cost-effectiveness compared to whole-genome sequencing
CES leverages NGS to focus on clinically relevant genes, ensuring precise and actionable results.
Clinical Applications and Conditions Detected
CES is indicated for patients with suspected genetic disorders, unexplained developmental delays, congenital anomalies, or a family history of hereditary cancer. The test can identify:
| Category | Examples |
|---|---|
| Mendelian Disorders | Cystic fibrosis, Huntington’s disease, sickle cell anemia |
| Oncological Variants | BRCA1/2, Lynch syndrome genes, somatic mutations |
| Neurodevelopmental Disorders | Autism spectrum disorder, intellectual disability |
| Pharmacogenomics | CYP2D6, CYP2C19, TPMT variants affecting drug metabolism |
Why Choose CES Over Whole-Genome Sequencing?
Unlike whole-genome sequencing, which generates massive amounts of data, CES focuses on clinically relevant genes to provide precise insights at a lower cost. Physicians prefer CES because it:
- Identifies exact variants causing disease
- Reduces unnecessary information unrelated to clinical outcomes
- Supports personalized treatment planning and risk assessment
For a comparative overview, see the table below:
| Feature | Clinical Exome Sequencing | Whole-Genome Sequencing | Targeted Panels |
|---|---|---|---|
| Scope | All coding regions (exome) | Entire genome | Specific gene set |
| Cost | Moderate (₹20,000) | High | Low |
| Turnaround Time | 4–5 weeks | 6–8 weeks | 2–3 weeks |
| Clinical Utility | High for rare diseases | Broad research utility | Focused on known genes |
Cost and Turnaround Time
The Clinical Exome Sequencing test is priced at ₹20,000.
Turnaround Time: 4–5 weeks
Result Delivery: Securely sent to your email
Privacy and Genetic Data Security
All genomic data are handled under strict national laboratory and health privacy guidelines. Patients sign a consent form specifying how their genetic information will be stored and used, ensuring confidentiality and compliance with regulations. DNA Labs India is an ISO 9001 certified lab, adhering to rigorous quality standards.
How to Get Tested at DNA Labs India
DNA Labs India is a leading molecular diagnostics provider, offering clinical exome sequencing across 180+ cities in India. Our services include:
- Safe, confidential sample collection
- Home sample collection for convenience
- Expert guidance and counseling for test interpretation
Major City Helplines:
- New Delhi: (011) 40849842
- Mumbai: (022) 48937160
- Kolkata: (033) 40836441
- Chennai: (044) 48137110
- Bangalore: (080) 45684079
- Hyderabad: (040) 49171772
- Ahmedabad: (079) 49107674
Booking: Visit www.dnalabsindia.com to schedule your test online or call your nearest branch.
Frequently Asked Questions (FAQ)
Q1. What is Clinical Exome Sequencing (CES)?
CES is a DNA test that screens clinically relevant coding regions of the genome to identify disease-causing genetic variants.
Q2. How is CES different from whole-genome sequencing?
CES focuses on clinically validated genes, providing precise insights at lower cost, while whole-genome sequencing generates all genomic data, much of which may not be clinically relevant.
Q3. What conditions can CES detect?
CES can detect Mendelian disorders, somatic mutations linked to cancers, autism, Alzheimer’s, and genetic variations affecting drug response.
Q4. How long does it take to get CES results?
Results are typically available in 4–5 weeks and sent securely via email.
Q5. Is my genetic data safe with DNA Labs India?
Yes, all data are handled according to strict privacy and regulatory guidelines, with consent forms detailing usage and storage.